A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Incyte Corporation
Incyte Corporation
Institute of Hematology & Blood Diseases Hospital, China
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Therapeutic Advances in Childhood Leukemia Consortium
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
St. Jude Children's Research Hospital
University Hospital Schleswig-Holstein
Mesoblast, Ltd.
Gruppo Italiano Malattie EMatologiche dell'Adulto
St. Jude Children's Research Hospital
Dutch Childhood Oncology Group
Gruppo Italiano Malattie EMatologiche dell'Adulto
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Sun Yat-sen University
Children's Oncology Group
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
SWOG Cancer Research Network
Associazione Italiana Ematologia Oncologia Pediatrica
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
University of California, San Francisco
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
Children's Oncology Group
University Hospital Schleswig-Holstein
Northwestern University
Swiss Cancer Institute
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Office of Rare Diseases (ORD)